Search
for
Sort by
Research 121–150 of 931
- Cartilage to bone transformation during fracture healing is coordinated by the invading vasculature and induction of the core pluripotency genes
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Lupus erythematosus: systemic and cutaneous manifestations
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Adult polycystic ovary syndrome begins in childhood
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- K channel therapeutics at the bedside
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Function and underlying mechanisms of seasonal colour moulting in mammals and birds: what keeps them changing in a warming world?
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Congenital Adrenal Hyperplasia
- Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome
- Polycystic Ovarian Syndrome
- Health and fertility in World Health Organization group 2 anovulatory women
- What causes hidradenitis suppurativa ?—15 years after
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Toxic Epidermal Necrolysis
- Acquired Zinc Deficiency
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Dermatology of androgen-related disorders
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Autoimmune Polyglandular Syndrome Type 1 in Russian Patients: Clinical Variants and Autoimmune Regulator Mutations
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Engineering Pro‐Regenerative Hydrogels for Scarless Wound Healing